血液检测市场[按检测类型（葡萄糖检测、血脂、肝功能检测、前列腺特异性抗原、激素、血尿素氮、高敏C反应蛋白、促甲状腺激素、血清尼古丁/可替宁）；按产品类型（仪器、软件和服务、试剂和检测试剂盒）；按最终用户（实验室、，医院、医疗点（POC）检测和血库）；按地区分类和预测，2017-2026年

Report Summary

2017年，全球血液检测市场预计为523.161亿美元，预测期内预计复合年增长率为2.6%。验血是在实验室里分析血液样本的医学过程，这些血液样本是用针头或指尖从病人手臂的静脉中采集的。血液测试有助于确定患者的生化和生理状态，分析药物的疗效，确定器官功能，诊断疾病，评估矿物质含量，并发现药物滥用。

全球市场受到以下因素的推动：献血和器官捐献激增，对献血安全的认识提高，人口老龄化增加，对献血的需求增长，细菌和病毒性疾病等传染病以及艾滋病毒、癌症等其他疾病的流行率上升，甲状腺和遗传疾病。此外，越来越多的医生倾向于以血液为基础的诊断，以确保可靠和快速的结果和新兴的医疗点（POC）检测中心的数量已导致市场的螺旋式增长。然而，测试成本的增加和熟练劳动力的缺乏可能会在一定程度上阻碍市场的增长。此外，发展中国家患者对自我检测产品和家庭诊断检测的认识的提高，以及开发新检测技术的研发，有望在不久的将来为市场增长提供重大机遇。

Blood Testing Market Scope

By Test Type	按产品类型	By End-Users	By Region
Glucose testing 脂质谱 肝功能检查 前列腺特异性抗原 Hormones Blood Urea Nitrogen High-sensitivity C-reactive protein Thyroid stimulating hormone 血清尼古丁/可替宁 其他	仪器 Software and Services Reagents & Testing Kits	Laboratory Hospitals Point of Care (POC) Testing 血库	North America (U.S., Canada) Europe (Germany, UK, France, Italy, Spain, Belgium, Russia, Netherlands) Asia-Pacific (China, Japan, India, Australia, Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines) Latin America (Brazil, Mexico, Argentina) 中东和非洲(阿拉伯联合酋长国、沙特阿拉伯、韩国frica)

Know more about this report:样本页请求

分部分析

The global blood testing market is segmented on the basis of type of tests, product type, end-users and geography. Based on the type of tests, the market is categorized into glucose testing, lipid profile, liver function tests, prostate specific antigen, hormones, blood urea nitrogen, high-sensitivity C-reactive protein, thyroid stimulating hormone, serum nicotine/cotinine and others. Depending on the product type, the market is divided into Instruments, Software and Services and Reagents & Testing Kits; and based on end-users the market is segmented into laboratory, hospitals, POC testing and blood banks.

区域分析

The report analyzes the global market across North America, Germany, Asia-Pacific, Latin America, and Middle East & Africa (MEA). North America is further segmented into U.S., Canada. Europe is divided into Germany, UK, Russia and Rest of Europe. Asia-Pacific is bifurcated into India, China, Japan and Rest of Asia-Pacific. Latin America is categorized into Brazil and Mexico. Middle East & Africa comprise of South Africa, and Rest of Middle East & Africa.

竞争格局

The key players in the market are launching new products and gaining regulatory approval to maintain a competitive edge. For instance, in November 2017, ITL Biomedical launched Transfer Cap Set, which is the latest blood culture testing product which ensures the safe and effective transfer of culture samples from a bacterial collection bottle to a vacuum tube. Additionally, In September 2017, Abbott’s FreeStyle Libre Flash Glucose Monitoring System has cleared the US FDA approval which uses under-the-skin sensor wire to measure the blood glucose levels, thereby eliminating the need of finger pricking. Moreover, In January 2017, Abbott has received the CE Mark for its Alinity System used for plasma and blood screening. The other key players operating in the industry include Abbott Laboratories, Alere, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Beckman Coulter, bioMérieux SA, Biomerica Inc., Bruker Corporation, Cepheid, Nanosphere, Inc., Nipro Diagnostics, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific, Inc., and Trinity Biotech PLC. Market players have adopted various strategies such as such as merger & acquisitions, novel product development, venture capital investments among others to expand their foothold and increase their customer base. Geographically, North America accounted the largest share in the global blood testing market in 2017.